The New York Times has published its annual fall theater preview, naming 41 productions worth seeing across the United States this season. The list, headlined “‘Liberation,’ ‘Purpose’ and 39 More Shows to See in the U.S. This Fall,” singles out Bess Wohl’s “Liberation” and Branden Jacobs-Jenkins’s “Purpose,” both Pulitzer Prize winners, as the marquee titles anchoring the lineup.
The Times describes the season as “rich with sharp productions,” pointing to a mix of prize-winning drama, an extended hit comedy in Cole Escola’s “Oh, Mary!” and genre-crossing new work like the hip-hop musical “Mexodus.” The selections suggest a season built as much around proven writers returning to the stage as around shows that have already found audiences and are simply continuing their run into the fall.
The headline productions: Bess Wohl’s “Liberation” and Branden Jacobs-Jenkins’s “Purpose”
Wohl and Jacobs-Jenkins arrive this season as two writers whose recent work has already cleared theater’s highest bar: the Pulitzer Prize for Drama. The Times places “Liberation” and “Purpose” at the top of its list, treating them as the productions most likely to define the fall conversation among critics and audiences alike.
Beyond the prize recognition, the Times summary gives no additional plot or production detail for either show, framing them instead by the pedigree of their authors. Both writers have built reputations for tackling weighty subject matter with structural ambition, and their inclusion signals that this season’s most anticipated shows are being sold on writerly credibility rather than star casting or spectacle.
Why these two Pulitzer winners are anchoring the season
Pairing two Pulitzer winners at the top of a single seasonal preview is a deliberate editorial choice. It tells readers that the season’s prestige productions aren’t one-offs but part of a pattern: playwrights who have already won theater’s most significant American honor are returning with new or continuing work in the same few months. For a fall preview trying to distill dozens of options into a manageable list, leading with “Liberation” and “Purpose” gives readers an immediate, credential-backed reason to prioritize those two titles over the other 39.
Cole Escola’s “Oh, Mary!” extends its run as the season’s word-of-mouth hit
“Oh, Mary!” is the outlier on the list in one respect: it isn’t new. The Times notes the show is extending its run this fall, a sign that the comedy, written by and starring Cole Escola, has sustained enough demand to keep selling tickets well past its original engagement. That kind of extension is typically theater’s clearest market signal: audiences and word of mouth, not press alone, are what push a limited run into an open-ended one.
Its inclusion alongside two brand-new Pulitzer winners is notable. It suggests the Times is treating “Oh, Mary!” as a genuine fall destination, one whose comedic voice offers a counterweight to the more serious-minded “Liberation” and “Purpose” on the same list.
“Mexodus” brings hip-hop storytelling to the fall lineup
“Mexodus” is the season’s clearest example of formal experimentation, described by the Times simply as a “hip-hop musical.” Its presence alongside prestige drama and an extended comedy hit rounds out a fall preview that spans genre rather than sticking to a single register. Where “Liberation” and “Purpose” carry the weight of literary prize culture and “Oh, Mary!” carries proven commercial staying power, “Mexodus” represents the season’s bet on musical innovation.
The Times offers no further plot detail on “Mexodus” in its summary, but its placement in the same sentence as two Pulitzer winners and a hit comedy is itself the story: the paper is positioning it as a peer to the season’s more established titles, not a footnote.
Beyond Broadway: the other 39 shows shaping the national theater scene
The bulk of the Times list, 39 productions beyond the four headliners, is described only in aggregate as part of a season “rich with sharp productions.” The paper does not break out individual titles, creative teams, or venues for these shows in its summary, framing them instead as evidence of depth across the fall calendar rather than as isolated must-sees.
That structure, a small number of named headliners followed by a much longer unnamed tail, is typical of the Times’ seasonal preview format, which reads less like a ranked top-ten list and more like a reference guide meant to be consulted title by title. Readers looking for the full scope of what’s opening this fall would need to consult the complete list published by the Times rather than relying on the four productions singled out in the headline.
Regional and off-Broadway productions rounding out the list
The Times headline frames its selections as shows to see “in the U.S.” rather than in New York alone, indicating the list extends beyond Broadway and Manhattan’s off-Broadway houses into regional theater. The paper’s summary does not specify which cities or companies are included among the 39 additional productions, but the national framing distinguishes this preview from a Broadway-only roundup and suggests the fall season’s strongest work isn’t confined to a single market.
What this season signals about American theater in 2024
Taken together, the four named productions point to a season defined by range rather than a single trend. Two Pulitzer-winning dramas, an extended comedy phenomenon, and a genre-bending musical don’t share a theme so much as a common trait: each has already proven, through prize committees, audience demand, or critical attention, that it can hold a stage.
That mix says something about how the Times is framing the fall for its readers. Rather than betting the season’s identity on one big new commercial musical or a single starry revival, the paper’s headline choices spread the emphasis across a serious new drama, a comedy with staying power, and a musical built around a specific idiom. The result is a preview that reads less like a hype list and more like a survey of where American theater’s momentum currently sits.
New work versus established playwrights
The season’s headliners split cleanly between new work and continuing runs. “Liberation” and “Purpose” are new plays from writers already carrying Pulitzer credentials, while “Oh, Mary!” is extending because it already found its audience. “Mexodus” sits in between: a newer work distinguished by form rather than by an existing award. That balance, between debuting prestige work and sustaining proven hits, is consistent with how theater seasons typically function. New plays need room to prove themselves, while hits that have already proven themselves get extended rather than closed on schedule.
Where and when to see these productions
The Times’ summary does not specify exact opening dates, closing dates, or venues for the 41 productions on its list, framing the guide instead as a season-long reference for “this fall” in the United States. Readers interested in specific tickets, run dates, or theater locations for “Liberation,” “Purpose,” “Oh, Mary!,” “Mexodus,” or any of the 39 additional shows should consult the Times’ full published list directly, since scheduling details vary by production and city.
What’s clear from the headline alone is the shape of the season: two new Pulitzer-winning plays opening this fall, a comedy hit extending its run rather than closing, and a hip-hop musical joining a lineup the Times describes as spanning the country. For theatergoers deciding where to spend a fall ticket budget, that’s the shortlist worth starting with before working through the remaining 39.
Be the first to comment